Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
Provided By GlobeNewswire
Last update: Apr 24, 2025
TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox
TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa monkeypox virus
Read more at globenewswire.com
